Skip to main content
  1. Home
  2. Emerging Tech
  3. Legacy Archives

3L Labs puts a fitness tracker in your shoe

Add as a preferred source on Google

CES is yet to officially get underway, but various product previews and announcements are already filtering out. One of the more interesting early titbits to come out of Las Vegas is the Footlogger from 3L Labs: this fitness tracker fits inside your shoe rather than around your wrist, and could potentially help spot health problems early as well as monitor your daily jog.

Head over to the product’s rather antiquated official website for more details on the Footlogger, which incorporates a three-axis accelerometer and eight different pressure sensors. With a memory capacity of 50,000 footprints, wireless Bluetooth capabilities and a 24-hour battery life between charges, the gadget could tempt anyone looking to get a better idea of their exercise habits.

Recommended Videos

According to 3L Labs, the Footlogger will be able to record your running and walking speeds, a history of your daily movements and how many calories you’re burning as well as the number of steps you’re getting through. The company also claims its tracker can be used to measure weight distribution, so athletes could use it improve their technique, for example.

Other potential applications for the device include helping with patient rehabilitation (after spinal or nervous system injuries) or even spotting the early signs of arthritis and dementia. Eventually, you might also be able to use the Footlogger to control your favorite video game, be it a futuristic first-person shooter or an Olympics simulation.

At the end of the day you’ll be able to place your sneakers on a wireless charger. Data pulled from your activities will be crunched by 3L Labs and could be returned to you (or your coach) via SMS text or a smartphone app. As yet we have no details on pricing or a launch date, but presumably we’ll be hearing more from 3L Labs at CES — stay tuned to Digital Trends for all the CES 2014 news stories and product announcements as they happen.

David Nield
Former Contributor
Dave is a freelance journalist from Manchester in the north-west of England. He's been writing about technology since the…
Students who use AI every day may be falling behind, while moderate users pull ahead
New global testing data suggests more AI in the classroom isn't automatically better.
Logo, Text

I assumed more AI access might help students learn faster. However, a new OECD study dispels that misconception for me and everyone else who gave their children a paid version of AI chatbots, thinking it would help them through their educational journey. 

According to PISA 2025 data from 760,000 students in 91 countries, students who use AI daily score meaningfully worse on standardized tests than their peers. The full picture is more complicated than a simple ban would fix.

Read more
XPENG just put its humanoid robot on the production line, and it walked itself out
IRON clocks in for its first shift
XPENG Iron

XPENG’s humanoid robot has officially joined the workforce, and it even got an employee badge. The Chinese automaker announced on September 8 that its next-generation IRON had completed assembly and autonomously walked off its newly commissioned humanoid robot production line in Guangzhou.

CEO He Xiaopeng then pinned a staff badge onto the robot, symbolically welcoming it to the XPENG team. It is a charming little ceremony for a machine that the company hopes will eventually become a regular part of everyday life. XPENG is moving IRON beyond R&D prototypes toward production-line manufacturing, applying the quality-control systems and manufacturing experience it has developed through its electric vehicle business.

Read more
An AI-designed drug might help slow aging, but we’re not there yet
The results hint at a possible anti-aging effect, but there’s still a long way to go before we know what it means.
medical test tubes

Rentosertib, a drug Insilico Medicine designed almost entirely using AI, was created to treat idiopathic pulmonary fibrosis, a disease that scars and stiffens the lungs over time. But fighting lung disease was only half the plan from the start.

According to a new study published in Nature Biotechnology, the drug's target was chosen specifically because it overlaps heavily with the biology of aging, and the whole trial was designed to test whether treating the lungs could also mean turning back the body's biological clock.

Read more